Design and construction of artificial blood vessels

New Frontiers in Angiogenesis

Volumn , Issue , 2006, Pages 111-124

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Weber, Elisabetta ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951832531     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-4327-9_6     Document Type: Chapter

References (40)

1. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res, 92:827-839, 2003.
2. Eagle K, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, Gott JP, Hermann HC, Marlow RA, Nugent WC, O'Connor GT, Orszulak TA, Rieselbach RE, Winters WL, Yusuf S. ACC/AHA guidelines for coronary artery bypass graft surgery. J Am Coll Cardiol, 34:1262-1347, 1999.
3. Rosenman JE, Kempczinski RF, Pearce WH, Silberstein EB. Kinetics of endothelial cell seeding. J Vasc Surg, 2:778-784, 1985.
4. Kao WJ. Evaluation of leukocyte adhesion on polyurethanes: the effects of shear stress and blood proteins. Biomaterials, 21:2295-2303, 2000.
5. Mikuki SA, Greisler H. Understanding and manipulating the biological response to vascular implants. Semin Vasc Surg, 12:18-26, 1999.
6. Herring M. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery, 84:498-504, 1978.
7. Herring M, Gardner A, Glover J. Seeding endothelium onto canine arterial prostheses. The effects of graft design. Arch Surgery, 114:679-682, 1979.
8. Herring MB, Dilley R, Jersild RA Jr, Boxer L, Gardner A, Glover J. Seeding arterial prostheses with vascular endothelium. The nature of the lining. Ann Surg, 190:84-90, 1979.
9. Ott M, Ballermann BJ. Shear stress-conditioned, endothelial cell-seeded vascular grafts improved cell adhesion adherence in response to in vitro shear stress. Surgery, 117:334-339, 1995.
10. Foxall TL, Auger KR, Callow AD, Libby P. Adult human endothelial cell coverage of small-caliber Dacron and polytetrafluoroethylene vascular prostheses in vitro. J Surg Res, 41:158-172, 1986.
11. Zilla P, Fasol R, Preiss P, Kadletz M, Deutsch M, Schima H, Tsangaris S, Groscurth P. Use of fibrin glue as a substrate of PTFE vascular grafts. Surgery, 105:512-522, 1989.
12. Thomson GJ, Vohra RK, Carr MH, Walker MG, 1991. Adult human endothelial cell coverage of small-caliber dacron and polytetrafluoroethylene vascular grafts: a comparison of four substrates. Surgery, 109:20-27, 1991.
13. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA, 94:6471-6475, 1987.
14. Holland J, Hersh L, Bryham M, Onyiriuka E, Ziegler L. Culture of human vascular endothelial cells on a RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: comparison with fibronectin-coated tissue grade polystyrene. Biomaterials, 17:2147-2156, 1996.
15. Hubbell JA, Massia SP, Desai NP, Drumheller PD. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechniques, 9:568-573, 1991.
16. Massia SP, Hubbell JA. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin α4β1. J Biol Chem, 267:14019-14026, 1992.
17. Tiwari A, Salacinski HJ, Punshon G, Hamilton G, Seifalian AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J, 16:791-796, 2002.
18. Edelman ER. Vascular tissue engineering: designer arteries. Circ Res, 85:1115-1117, 1999.
19. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science, 231:397-400, 1986.
20. Shinoka AT, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacant JP, Mayer JE Jr. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg, 115:536-545, 1998.
21. Shin'oka AT, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. New Engl J Med, 344:532-3, 2001.
22. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24:2303-2308, 2003.
23. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries growth in vitro. Science 284:489-493, 1999.
24. Opitz F, Schenke-Layland K, Ritcher W, Martin DP, Degenkolbe I, Wahlers T, Stock UA. Tissue engineering of bovine aortic blood vessel substitutes using applied shear stress and enzymatically derived vascular smooth muscle cells. Annals of Biomedical Engineering, 32:212-22, 2004.
25. Opitz F, Schenke-Layland K, Cohnert TU, Starcher B, Halbhuber KJ, Martin DP, Stock UA. Tissue engineering of aortic tissue: direct consequence of suboptimal elastic fiber synthesis in vivo. Cardiovasc. Res. 63:719-730, 2004.
26. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res, 85:1173-1178, 1999.
27. Xu CY, Inai R, Kotaki M, Ramakrishna S. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel enginnering. Biomaterials 25:877-886, 2004.
28. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Controlled Release, 72:101-113, 2001.
29. L'Heureux N, Paquet S, Labbé R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J, 12:47-56, 1998.
30. Barone LM, Faris B, Chipman SD, Toselli P, Oakes BW, Franzblau C. Alteration of the extracellular matrix of smooth muscle cells by ascorbate treatment. Biochim Biophys Acta, 840:245-254, 1985.
31. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev, 71:481-539, 1991.
32. Courtmann DW, Errett BF, Wilson GJ. The role of crosslinking in modifications of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res, 55:576-586, 2001.
33. Wilson FJ, Yeger H, Klement P, Lee JM, Courtmant DW. Acellular matrix allograft small caliber vascular prostheses. ASAIO Trans, 36:M340-M343, 1990.
34. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Havenich A. Engineering of human vascular aortic tissue based on a xenogenic starter matrix. Transplantation, 70:7-14, 2000.
35. Huynh T, Abraham G, Murray Y, Brockbank K, Hagen PO, Sullivan S. Remodeling of an acellular collagen graft into a physiologically responsive neovessels. Nature Biotechnol, 17:1083-1086, 1999.
36. Remy-Zolghadri M, Laganiere J, Oligny JF, Germain L, Auger FA. Endothelium properties of a tissue-engineered blood vessel for small-diameter vascular reconstruction. J. Vasc. Surg. 39:613-620, 2004.
37. Leung DYM, Glagow S, Mathews MB. Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science, 191:475-477, 1976.
38. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Bicohem J, 247:597-604, 1987.
39. Geesin JC, Darr D, Kaufman R, Murad S, Pinnel SR. Ascorbic acid specifically increases type I and type III procollagen messanger RNA levels in human skin fibroblasts. J Invest Dermatol, 90:420-424, 1988.
40. Eyre D. Cross-linking in collagen and elastin. Annu Rev Biochem 34:1262-1347, 1984.